GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis
about
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNSInhibition of the Wnt signaling pathway by Idax, a novel Dvl-binding proteinSynergistic activation of the Wnt signaling pathway by Dvl and casein kinase IepsilonProtein phosphatase 1 regulates assembly and function of the beta-catenin degradation complexDirect, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damagePontin52 and reptin52 function as antagonistic regulators of beta-catenin signalling activityWnt/beta-catenin signaling and small molecule inhibitorsGSK-3: tricks of the trade for a multi-tasking kinaseTissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of beta-catenin in ovarian tumoursEstablishment of the dorsal-ventral axis in Xenopus embryos coincides with the dorsal enrichment of dishevelled that is dependent on cortical rotationElevated levels of beta-catenin and fibronectin in three-dimensional collagen cultures of Dupuytren's disease cells are regulated by tension in vitroExposure to the herbicide acetochlor alters thyroid hormone-dependent gene expression and metamorphosis in Xenopus LaevisMolecular specification of germ layers in vertebrate embryosGSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synucleinStructural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complexA GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and beta-cateninbeta-catenin signaling and cancerStabilization of beta-catenin by a Wnt-independent mechanism regulates cardiomyocyte growthCasein kinase I epsilon enhances the binding of Dvl-1 to Frat-1 and is essential for Wnt-3a-induced accumulation of beta-cateninMood stabilizers, glycogen synthase kinase-3beta and cell survivalbeta-catenin destruction complex: insights and questions from a structural perspectiveFRAT-2 preferentially increases glycogen synthase kinase 3 beta-mediated phosphorylation of primed sites, which results in enhanced tau phosphorylationLight and electron microscopy study of glycogen synthase kinase-3beta in the mouse brainCell autonomous regulation of multiple Dishevelled-dependent pathways by mammalian NkdInteraction of dishevelled and Xenopus axin-related protein is required for wnt signal transduction.ERK1/2 antagonizes glycogen synthase kinase-3beta-induced apoptosis in cortical neuronsNuclear localization of Duplin, a beta-catenin-binding protein, is essential for its inhibitory activity on the Wnt signaling pathwayEvidence for a role of glycogen synthase kinase-3 beta in rodent spermatogenesisFrat is dispensable for canonical Wnt signaling in mammalsA divergent canonical WNT-signaling pathway regulates microtubule dynamics: dishevelled signals locally to stabilize microtubulesInteraction among GSK-3, GBP, axin, and APC in Xenopus axis specificationGlycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithiumVegetally localized Xenopus trim36 regulates cortical rotation and dorsal axis formation.Genotype-specific responses in Atlantic salmon (Salmo salar) subject to dietary fish oil replacement by vegetable oil: a liver transcriptomic analysis.Wingless directly represses DPP morphogen expression via an armadillo/TCF/Brinker complexMechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways.Postgenomic technologies targeting the Wnt signaling network.Regulation of glycogen synthase kinase 3beta and downstream Wnt signaling by axinTestosterone prevents the heat shock-induced overactivation of glycogen synthase kinase-3 beta but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase and concomitantly abolishes hyperphosphorylation of tau: implications for Alzheimer's dGlycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility.
P2860
Q21129334-2E5F73D0-B400-475E-83BB-F534FEA540F9Q24290612-0F7CAD9E-B8CE-4D7E-8329-DC8FD712BF48Q24291365-D5F4CD09-D1FC-4FF6-AD52-27F4291114D8Q24298111-A5E04B85-B4F8-47E9-98F3-A3352A2242D6Q24534352-04C12F9A-AC3C-49FD-9E4A-38A19E5036C2Q24597019-23A61361-3655-4165-9482-1A3883694199Q24597197-B3A9507B-A13E-46D5-9254-EEC45BAF5B19Q24624069-FB86A8DB-88BF-4056-A6D3-5AED1A1D5009Q24651981-5130C88A-6ACB-4B70-8261-D8E6A79005C2Q24683274-8DE6E973-5F3E-4676-AF6B-9FDE009594F8Q24793854-CBAFBA72-3683-41AE-8390-9C2998957D30Q24811435-D74E6824-2922-4B7B-9F00-AA94597D2A27Q26775874-9312DF59-7B3B-4304-B313-37BF245A9518Q27331743-F6CE16F2-BAA1-4290-97DA-7174DD79AFC3Q27640372-A92A5DBF-8149-4D3C-8944-2CFC9A125433Q28115262-CA3FC13D-6E08-4456-BE7C-B719AEC5B641Q28139147-074977B5-1DA9-4CF8-96FD-83CFBDDE2B5FQ28187862-AFDD8BE1-A823-4E71-9295-56EE53CB63B6Q28205993-DE774D8F-5392-4C05-BABD-CB2A33D9B1B4Q28216404-9CE5FBB0-8E99-444E-8110-1D01818380BAQ28276987-9E730017-41B7-41F4-882E-66C6E3982CB1Q28291371-45A3B619-3BAF-4592-B962-BAC695BF4066Q28472669-525F74CB-DAD5-40F4-985B-468DA3B63596Q28507761-DF87EF29-ECE5-4C74-A99E-2119AB88CF25Q28509243-BE7A968C-E16B-44AD-B91D-A3AE775CD0C0Q28568735-2E95800B-8736-451C-8DB7-BD029743A901Q28571000-8C70C481-E7BB-4FBC-BB11-73405ECEA841Q28571569-A734F69E-F920-4223-AB2C-0E691703299DQ28585212-4635F31D-8EB1-45D8-BB13-0599D4BAB121Q28586223-6E0C2D36-6E18-4A00-86B7-6CA56395D675Q28640539-D5635F79-48AC-483B-8D98-00D5D24F5C48Q30362607-32991A67-CE18-4B1D-A511-9AFF694D49E3Q30489673-34E76546-8FAE-48BD-BAA9-F4B733AD855DQ31014058-0C88553E-3D2D-4A5A-93F0-463C47E5B745Q33268349-45496FD7-52FB-47D2-8FCD-CFF89AAEF0D6Q33814311-A9DDF1EF-26A8-4740-A009-19AB1E79B71CQ33838680-08AE697B-6C50-4D48-8A96-A7D3EE271C22Q33959834-97A5F6B1-6D7F-409E-94F9-BF77CD40AF88Q34008372-1734EE90-4555-4D8F-A503-8FD8D6FA3646Q34085646-7BF70E57-4B32-4E7B-9A5E-A1D8095663C0
P2860
GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis
@ast
GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis
@en
GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis
@en-gb
GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis
@nl
type
label
GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis
@ast
GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis
@en
GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis
@en-gb
GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis
@nl
prefLabel
GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis
@ast
GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis
@en
GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis
@en-gb
GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis
@nl
P2093
P3181
P1433
P1476
GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis
@en
P2093
P304
P3181
P356
10.1016/S0092-8674(00)81208-8
P407
P577
1998-06-12T00:00:00Z